CORPORATES HEALTH Caplin Point subsidiary secures USFDA final approval for Desmopressin Acetate Injection ANDA Feb 28, 2026
CORPORATES HEALTH Caplin Point subsidiary secures USFDA approval for Sodium Phosphates Injection Feb 24, 2026
CORPORATES HEALTH Caplin Point subsidiary receives USFDA approval for Methylprednisolone Acetate Injectable Jan 27, 2026
Caplin Point shares surge 5% as Q1 revenue jumps 11% YoY to Rs 510 crore, net profit up 23.2% YoY Aug 7, 2025
Caplin Point subsidiary Caplin Steriles gets USFDA approval for Phytonadione Injectable Emulsion Apr 23, 2025
Caplin Point Laboratories subsidiary gets USFDA nod for Levetiracetam in sodium chloride injection Jan 17, 2025